International evaluation of an AI system for breast cancer screening

Journal: Nature

Published: 2020-01-01

DOI: 10.1038/s41586-019-1799-6

Affiliations: 14

Authors: 31

Go to article
Institutions Share
Google DeepMind, United Kingdom (UK) 0.29
Google LLC, United States of America (USA) 0.26
Department of Medicine, NU, United States of America (USA) 0.10
Google London, United Kingdom (UK) 0.10
Royal Surrey County Hospital NHS Trust, United Kingdom (UK) 0.06
NIHR Cambridge Biomedical Research Centre (Cambridge BRC), United Kingdom (UK) 0.03
Verily Life Sciences LLC, United States of America (USA) 0.03
Department of Surgery and Cancer, ICL, United Kingdom (UK) 0.03
Institute of Global Health Innovation, ICL, United Kingdom (UK) 0.03
Stanford Health Care, United States of America (USA) 0.02
VA Palo Alto Healthcare System (VAPAHCS), United States of America (USA) 0.02
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK) 0.02
Cheltenham General Hospital, GHNHSFT, United Kingdom (UK) 0.02
Research UK Centre Imperial Cancer, ICL, United Kingdom (UK) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER